Lv2
168 积分 2022-03-22 加入
Rapid CAR-T manufacturing with low-intensitypriming enhances CAR-T cell fitness and limitsinflammatory programming in a phase 1 study
4天前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
How I Treat Thrombotic Microangiopathy in the Setting of Triggers
2个月前
已关闭
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
4个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
4个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 tria
4个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
4个月前
已完结
Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse
5个月前
已完结
T cell lymphomas: cancers of aberrant immune synapse signalling
5个月前
已完结
The 10 commandments of immunoregulation in lymphoma
6个月前
已关闭
皖公网安备34019202002308
